Top Markets
Coin of the day
Oxford Cannabinoid Technologies Holdings Plc Oxford Cannabinoid Technologies Holdings Plc

Oxford Cannabinoid Technologies Holdings Plc

OCTP
Rang in Aktien #41534
Oxford Cannabinoid Technologies Holdings Plc operates as a pharmaceutical... Oxford Cannabinoid Technologies Holdings Plc operates as a pharmaceutical company, focused on the research, development, and commercialization of cannabinoid-derived prescription medications. Their principal drug candidate, OCT461201, is a selective CB2 receptor agonist in an oral solid dosage format, currently undergoing pre-clinical assessment. It is being developed to target visceral pain associated with Irritable Bowel Syndrome (IBS), as well as a range of neuropathic pain conditions, notably post-herpetic neuralgia. The company is also progressing with OCT130401, another compound in pre-clinical development, intended for the treatment of trigeminal neuralgia. Incorporated in 2017, Oxford Cannabinoid Technologies Holdings Plc is based in London, United Kingdom.
Aktienkurs
$0.00156481
Zuletzt synchronisiert: 2024-06-05
Marktkapitalisierung
$17.03K
Veränderung (1 Tag)
2.11%
Veränderung (1 Jahr)
0.00%
Land
GB
Handel Oxford Cannabinoid Technologies Holdings Plc (OCTP)

Kategorie

Dividendenrendite-Verlauf für Oxford Cannabinoid Technologies Holdings Plc (OCTP)
Dividendenrendite (TTM) von Oxford Cannabinoid Technologies Holdings Plc (Aktienkürzel: OCTP) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für Oxford Cannabinoid Technologies Holdings Plc (OCTP) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber